Category Archives: Health: Addiction

Addiction one of the Largest growing Problem’s in the world today. This Press Release Service will bring you the newest services and research available.

SunWave Health ‘Steps to Recovery’ Helps Lower Pennsylvania Overdose Death Rates and Honors Innovation During “A Night to Remember


“The barriers and inequities faced by minority populations and the impact that socioeconomic determinants have on the risk of overdose death require that our providers create custom and tailored treatment pathways to improve outcomes.”

As part of International Overdose Awareness Day, Steps to Recovery—a CIVIQ health provider—and Sunwave Health will honor innovation and commitment to lowering overdose rates during the annual “A Night to Remember” event.

In honor of International Overdose Awareness Day, CIVIQ Health’s Steps to Recovery is partnering with Recovery Advocates of America and health IT provider for behavioral practices, Sunwave Health, to raise awareness of overdose deaths and to recognize community members and innovators who are helping reduce overdose rates across Pennsylvania, the state with one of the worst drug overdose mortality rates across the country. The three organizations will host “A Night to Remember” on August 25, 2022, with proceeds going to support Recovery Advocates of America and their efforts to provide education and tools that address addiction.

“Our team works tirelessly to drive outreach and connection throughout the community to lower the risk of overdose,” said Cory Cooper, chief executive officer for CIVIQ. “The COVID era exacerbated what was already a huge problem. And the rise of synthetic opioids created a perfect storm that has driven overdose rates skyward nationwide. This event and our activities around Overdose Awareness Day drive greater awareness and education on how to prevent overdose deaths within our immediate community.”

According to the Centers for Disease Control and Prevention, overdose deaths rose 30 percent between 2019 and 2020. The impact on minority and underserved communities is worse. Rates increased by 44 percent and 39 percent across Black and American Indian and Alaska Native populations, respectively. In Pennsylvania, home to CIVIQ, statewide rates increased by more than 19 percent between 2019 and 2020. But efforts to curb overdose death rates are expected to help Pennsylvania residents. The latest National Center for Health Statistics projections predict a more than half percentage point rate drop between 2021 and 2022. This makes Pennsylvania one of only four States with an anticipated improvement in overdose deaths.

“Our efforts to lower overdose rates within the surrounding area are powered by our people, their expertise, and the technology that connects patients, clinicians, and services,” said Lauren Nolan, director of quality assurance for CIVIQ. “Our partnership with Sunwave Health creates a seamless pathway to admitting, engaging, and staying connected with graduates from our program. It is this connection that helps us prevent overdose, and it is this connection that is helping lower overdose death rates in the communities that we serve.”

Established in August 2021, the Biden Administration created Overdose Awareness Week, observed from August 29 through September 4. Since the Presidential Action, substance use disorder providers and the larger behavioral health community set August 31 as International Overdose Awareness Day to help increase awareness and stimulate action and discussion on prevention efforts.

“Overdose deaths and addiction impact communities differently,” said Cooper. “The barriers and inequities faced by minority populations and the impact that socioeconomic determinants have on the risk of overdose death require that our providers create custom and tailored treatment pathways to improve outcomes. Doing that means we must have flexibility in our processes, deep connections to community resources, and technology that can adjust to our patients and workflow. Sunwave Health has been a critical piece to our success, and we are thrilled that they are our Ambassador for Recovery Award sponsor at this year’s Overdose Awareness Event.”

“Being part of Steps to Recovery’s efforts to lower overdose rates within the community illustrates the power of our partnership,” said Richard Daley, Sunwave Health’s chief executive officer. “We work to ensure a lasting and meaningful connection between providers and their patients to address overdose and lower relapse and readmissions. Steps to Recovery is a model for effective outreach and lasting positive addiction outcomes.”

Recovery Advocates of America, A 501(c)(3) non-profit peer-to-peer center that strives to provide education around the disease of addiction, will receive all proceeds from the event. A company spokesperson provided the following statement:

“We offer so much of ourselves to helping others into recovery because we have stood in the shoes of the homeless, incarcerated, and chronic relapsers. We have seen how substance use tears good families apart. We have stood with the families who lost a loved one to substance use and felt their pain. We know the immeasurable value of shared experiences. We throw ourselves to this mission because we don’t know if this is the time everything changes for them or if it is their first time trying to recover and they don’t know where to start, but we know that we want to be there to answer the call and ensure that they have all the resources available to give them the best chance at recovery.”

A Night to Remember will take place at the Steps to Recovery facility in Levittown, PA, from 6:00 PM until 8:30 PM on August 25, 2022. The event is open to the public. The family-friendly in-person event will feature a DJ, food trucks, and a raffle with all proceeds benefiting Recovery Advocates of America. Sunwave Health will present the Ambassador for Recovery award, recognizing a local individual for contributions and ongoing efforts to lower overdose rates. And for more information on overdose rates and the impact on specific communities, visit the Morbidity and Mortality Weekly Report (MMWR).

About Sunwave Health

Sunwave Health drives healthy results for behavioral health providers. We enable care quality, realize value, and improve resource optimization across the treatment journey. Every patient encounter encompasses multiple variables that can be hard to measure and manage without a holistic, end-to-end solution. Sunwave Health ensures visibility and transparency into admissions, drives predictability and insight into the patient census, accelerates payment, reduces reimbursement variability, and improves the clinician and patient experience across every treatment journey step. As a result, providers can better manage increased demand, improve clinical and non-clinical resource utilization, increase patient retention, and optimize reimbursement.

Sunwave Health’s solutions provide the scalability and flexibility needed to support multiple facility types and reimbursement models. Operational and clinical intelligence—powered by the underlying comprehensive, consolidated data approach—simplifies reporting and planning. Compliance and accreditation are accelerated, and providers are prepared for future value-based requirements. Sunwave Health protects the health of your practice and facility so that you can focus on the health of your patients. Sunwave Health—driving beneficial results.http://www.sunwavehealth.comhttp://www.sunwavehealth.com.

About CIVIQ

At CIVIQ Health, our mission is to enhance the well-being of individuals and families impacted by Addiction and Mental Health Disorders. We provide comprehensive, collaborative, and personalized behavioral health care. Our network of therapeutic resources makes Addiction and Mental Health Treatment both accessible and effective.

Share article on social media or email:

Explore the Trippy World of Hallucinogens at PAINWeek 2022, on Friday, September 9, at The Cosmopolitan of Las Vegas


PAINWeek Pain Management Conference, September 6-9

Psychedelic medicine has been stigmatized and isolated from us for too long. Now is the time to revolutionize care for addiction, pain, and mental health using whatever tools we have, and psychedelic medicine is the most promising potential weapon in this battle.

“Psychedelic medicine has been stigmatized and isolated from us for too long. Now is the time to revolutionize care for addiction, pain, and mental health using whatever tools we have, and psychedelic medicine is the most promising potential weapon in this battle,” states Dr. Eugene Vortsman, who will be presenting at the PAINWeek National Conference, September 6-9, at The Cosmopolitan of Las Vegas, during the Psychedelics Track on Friday, September 9.

His presentation is Purple Haze: Mysticism & Science of Psychedelics, about which Dr. Vortsman said, “to best understand the true potential of these powerful medicines it is important to understand the cultural and scientific history of hallucinogenics leading to the current landscape for future growth. Come on this psychedelic journey through time, space, and science. Together, we will explore the trippy world of hallucinogens.” Eugene Vortsman, DO, FACEP, is Clinical Director of Addiction Medicine and Disease Management at Northwell Health, Long Island Jewish Medical Center in Queens, NY.

“The psychological mechanism and insight gained during nonordinary states of consciousness is as important as the biological mechanism of the medication,” says Dr. Michelle Weiner. Her presentation is K Especial: The Biopsychosocial Model of Personalizing Ketamine for Pain Management. She continued, “practicing medicine during an opioid epidemic and mental health crisis has challenged physicians to evaluate if we are treating chronic physical and emotional pain effectively. Ketamine’s dose, route of administration, and setting can be personalized and integrated into the treatment plan.” Michelle Weiner DO, MPH, is an Integrative Pain Management Physician at the Spine and Wellness Centers of America in Miami, Florida.

Dr. Sanjey Gupta’s presentation, The Glass Bead Game: Harm Reduction and Its Potential Impact on the Opioid Crisis, will discuss the combination of programs, policies, and practices that aim to reduce the negative social, health, and legal implication associated with drug use. He commented, “we are pleased that PAINWeek is a leading source of education in harm reduction, as these initiatives are grounded in social justice and human rights.” Sanjey Gupta, MD, MBA, is a Professor of Emergency Medicine at the Zucker School of Medicine at Hofstra/Northwell Health, Rockville Centre, NY.

PAINWeek will present 90+ CME/CE credit hours in tracks such as Behavioral Pain Management, Chronic Pain Syndromes, Health Coaching, Interventional and Integrative Pain Management, Medical/Legal, Neurology, Physical Therapy, and Pharmacotherapy. Master Classes, Special Interest Sessions, and sponsored courses complement the agenda, along with tracks presented by The American Society of Interventional Pain Physicians and the International Pelvic Pain Society.

For more information, click PAINWeek or go to painweek.org.

PAINWeek accreditation provided by Global Education Group:

Global Education Group focuses on producing partnership-based CME for healthcare practitioners. The Global team works with a select group of medical education companies, associations, academic institutions, and healthcare facilities to develop and accredit live healthcare conferences and workshops as well as online activities. With each partnership or joint providership, Global brings accreditation expertise, project management excellence and grant funding intelligence. Based in Littleton, Colo., Global has accreditation with commendation from the ACCME and accredited with distinction from the ANCC. Global also holds accreditations to offer continuing education for nurse practitioners, pharmacists, dietitians, dentists, and psychologists. Global is a division of Ultimate Medical Academy.

###

Share article on social media or email:

Kevin and Marlo Coker’s newly released “Jesus Stole My Weed! A Testimony of Substance Abuse Freedom (and Other Life-Altering Stories)” is a uniquely enjoyable memoir.


News Image

“Jesus Stole My Weed! A Testimony of Substance Abuse Freedom (and Other Life-Altering Stories)”: a heartfelt story of hope and divine intervention. “Jesus Stole My Weed! A Testimony of Substance Abuse Freedom (and Other Life-Altering Stories)” is the creation of published authors Kevin and Marlo Coker.

Kevin and Marlo Coker share, “She’s a hot mess looking for the right love in all the wrong places. He’s a pothead in love with another girl. Somehow, they fall in love and try to make the love triangle work. But eventually, one of these things has to go. With God by their side and guiding their steps, the right choices are eventually made, in a unique and divine way.

“See how God helps them give up their addictions to create a beautiful life together. See how you can be encouraged to unfold the same story in your own life.”

Published by Christian Faith Publishing, Kevin and Marlo Coker’s new book will entertain and inspire as readers settle in for an open discussion of life’s challenges.

Kevin and Marlo Coker offer a private look into personal and shared struggles in hopes of helping others find a positive path forward.

Consumers can purchase “Jesus Stole My Weed! A Testimony of Substance Abuse Freedom (and Other Life-Altering Stories)” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Jesus Stole My Weed! A Testimony of Substance Abuse Freedom (and Other Life-Altering Stories),” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

AltaPointe Health is Working to Battle the Rise in Fentanyl and Methamphetamine Along the Gulf Coast


News Image

New data released by the Centers for Disease Control and Prevention in May 2022 showed a surge in overdose deaths involving fentanyl and methamphetamine. Overall, the nation saw a 15% increase in deaths from overdoses in 2021.

A growing share of deaths continue to come from overdoses involving fentanyl, a class of potent synthetic opioids that are often mixed with other drugs, as well as methamphetamine, a synthetic stimulant. And many of the deaths appeared to be the result of combining the two.

AltaPointe Health’s Deputy Chief Medical Officer Dr. Luke Engeriser says both fentanyl and methamphetamines are on the rise along the Gulf Coast.

DISGUISED DRUGS

“We have seen a large increase in the number of people presenting for services who are positive for both methamphetamine and fentanyl. The scary thing is that this also includes a lot of people who did not knowingly use either substance,” said Engeriser.

Engeriser explained that more and more frequently, street drugs are not really what they seem to be, but are actually methamphetamine or fentanyl in disguise.

“The DEA is finding that many drugs on the street that are shaped like tablets of popular opioids, like Lortab or Roxicet, are actually fentanyl pressed into the shape of those other drugs,” added Engeriser. “In May, three Ohio State University students overdosed on fake Adderall pills, and two of them died.”

Many street drugs are also being laced with methamphetamine or are actually methamphetamine disguised as something else like MDMA/ecstasy.

EASILY ACCESSIBLE & EXTREMELY ADDICTIVE

At AltaPointe Health, Dr. Engeriser says patients with methamphetamine addiction come from all social classes, ethnicities, genders, and ages.

“It is unfortunately very widely available in our community and is very inexpensive, costing less on the street than marijuana. It is such an addictive substance that anyone is potentially vulnerable to getting addicted to it,” explained Engeriser.

Methamphetamines are particularly addictive because they have a powerful affect on the reward center in the brain. Dr. Engeriser said even occasional use can disrupt the functioning of the brain so much that the person begins to crave the drug just to feel normal again.

HELP IS AVAILABLE

AltaPointe Health provides a number of substance use treatment outpatient programs, including a methadone and buprenorphine program. Anyone who is looking for help or more information can call AltaPointe’s access to care team at (251) 450-2211.

AltaPointe’s new Behavioral Health Crisis Center, located at 2401 Gordon Smith Drive in Mobile, can also help people who are trying to quit using alcohol, opioids, and methamphetamine with their withdrawal symptoms.

“Withdrawal from some of these substances like alcohol or benzodiazepines can be medically dangerous, and it is important to have medical monitoring and treatment for withdrawal rather than just quitting cold turkey,” said Engeriser.

After withdrawal is resolved, the Crisis Center can link individuals to community and inpatient treatment, based on need, upon discharge.

ABOUT ALTAPOINTE

AltaPointe Health is an extensive healthcare system providing primary and behavioral healthcare. Each year it provides more than 1 million services to 45,000 patients across Alabama. Rounding out the continuum, AltaPointe has two psychiatric hospitals serving children and adults, a 24-hour behavioral health crisis center, and 23 outpatient behavioral healthcare clinics. Its team of physicians serve as the administration and faculty for the University of South Alabama, College of Medicine-Department of Psychiatry. AltaPointe serves Mobile, Baldwin, and Washington counties in southwest AL and Clay, Coosa, Randolph, and Talladega counties in east-central AL. Tuerk Schlesinger is the Chief Executive Officer.

Share article on social media or email:

Issues of Life” is a reminiscent memoir that examines one’s life experiences in powerful detail.


News Image

“My Story: Issues of Life”: a potent autobiographical exploration of abuse, alcoholism, and time served in prison. “My Story: Issues of Life” is the creation of published author Larry Giles.

Giles shares, “This book is to the world to show the power of God—how God can change one life if he or she chooses to change. You see, God showed me love that I never had. I have so much love in my heart and that love God gave me has caused me to love something I never had.

“I have so much love in my heart today in this dying world. This world needs to learn how to have the love of God in them, and this will be a better world than what it is. Love is the key to life, but so many people have been hurt in their life, and they do not know how to love because most people never knew love. I was never told as a child about love; no one in my family said to me, ‘We love you, Larry.’

“I say now that love covers everything; to love others, you must be set free from the things of the past, but that is a process. Not only am I in this process, many other people are in a process too; but God has us in his hands, so never give up on God. I know I have not given up on God and the Lord Jesus Christ.”

Published by Christian Faith Publishing, Larry Giles’s new book is a truly inspiring story of one man’s journey through the lasting effects of neglect and abuse.

Giles shares in hopes of encouraging others to seek a connection with God in times of trouble and for strength to achieve healing.

Consumers can purchase “My Story: Issues of Life” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “My Story: Issues of Life,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

Lotus Recovery Centers Receives International Accreditation


CARF-Accredited Lotus Treatment Centers

Receiving a three-year CARF accreditation is a visible symbol to patients, their families and loved ones that Lotus Recovery Centers only delivers safe and effective treatment by dedicated staff.

Lotus Recovery Centers, a noted provider of addiction treatment services in West Virginia, has received a three-year accreditation by CARF International, an accolade signifying superior performance and dedicated to providing patients with tailored treatment for co-occurring addiction and mental health conditions.

Located at 129 Deanna Ave, Lotus Recovery Centers is a 13,000+ square foot full service facility that provides detox, residential treatment, medication-assisted treatment and other substance use treatment services to those who need it most, including veterans. Treatment offered at Lotus Recovery Centers incorporates substance use, mental health and holistic care, which gives patients a greater chance at building a solid foundation in their recovery.

“This distinction further establishes Lotus Recovery Centers as a facility in which high-quality care is delivered,” said CEO Ryan Collison. “Receiving a three-year CARF accreditation is a visible symbol to patients, their families and loved ones that Lotus Recovery Centers only delivers safe and effective treatment by dedicated staff.”

This accreditation decision represents the highest level of accreditation that can be given to an organization that shows substantial conformance to the CARF standards. An organization receiving a Three-Year Accreditation has put itself through a rigorous peer review process. It has demonstrated to a team of surveyors during an on-site visit its commitment to offering programs and services that are measurable, accountable, and of the highest quality.

“The entire staff is wholly committed to bettering the life of every one of our patients, and that is evidenced by this distinction,” said Chief Operating Officer David Stup. “Recognition of this magnitude is an honor and it substantiates the notion that Lotus Recovery Centers is at the forefront of treating the disease of addiction.”

About Lotus Recovery Centers

Lotus Recovery Centers is a substance use treatment facility that provides high-quality services and evidence-based treatment methods to those struggling with addiction, including veterans. Most commercial insurance plans, including Medicaid are accepted. We are available 24 hours a day, 7 days a week – if you or a loved one is struggling with addiction, call us at 888-918-2403 or email us at admissions-comfort@lotusrecoverycenters.com. For more information, please visit us at LotusRecoveryCenters.com.

Share article on social media or email:

Clay Phillips Joins Summit BHC as Senior Vice President of Strategy and Managed Care


Summit BHC (Summit), a leading national provider of behavioral health and addiction treatment services based in Franklin, Tennessee, has named Clay Phillips as Senior Vice President of Strategy and Managed Care.

“Clay’s deep knowledge of payer and governmental systems and his experience in healthcare innovation and value-based contracting will help Summit continue to lead in the behavioral healthcare space,” said Brent Turner, CEO of Summit. “We are thrilled to have him on board as we grow our footprint throughout the country.”

Phillips comes to Summit after 15 years at BlueCross BlueShield of Tennessee, where he served as Vice President of Network Innovation and Provider Performance Programs. His team focused on strategic development of value-based contracts and quality performance programs. He and his team also implemented new care delivery models and alternative payment programs.

“I’m excited to be on board with an experienced team dedicated to improving the behavioral health landscape and market,” Phillips said. “I look forward to working with this exceptional team to develop and foster strategic relationships across the country.”

During his time at BlueCross BlueShield of Tennessee, Phillips also served as Associate General Counsel and Director of Government Relations. Before joining Blue Cross, Phillips was an attorney with Miller & Martin, PLLC, where his practice focused on health care law, insurance regulation, and government relations.

About Summit

Headquartered in Franklin, Tennessee, Summit operates a leading network of behavioral health hospitals and addiction treatment centers throughout the country. The company’s primary focus is on psychiatric and substance use disorder treatment within a flexible and dynamic continuum of care. The leadership team at Summit is composed of senior executives with decades of combined experience in the behavioral healthcare industry. The company currently owns and operates 31 inpatient facilities nationwide.

Share article on social media or email:

One Of Asheville’s Top Addiction Treatment Centers Becomes An Official Member Of The NATSAP


Our membership with NATSAP will allow us to serve more men impacted by substance abuse. At the end of the day, the more effectively we can provide healing to our community, the better.

Next Step Recovery intensive outpatient and addiction recovery programs for men have recently joined the National Association of Therapeutic Schools and Programming. This membership acknowledges Next Step Recovery as an accredited institution and provides opportunities for this Asheville-based rehab facility to have additional access to resources, training, forums and committees that help further Next Step Recovery’s goal of providing healing to men struggling with addiction.

“We are constantly searching for ways to improve and provide the best resources possible to the men in our community,” says Susan Stader, founder and executive director of Next Step Recovery. “Our membership with NATSAP is reflective of our growth and our desire to always keep learning and finding better ways to serve.”

NATSAP was founded to “serve as an advocate and resource for innovative organizations which devote themselves to society’s need.” This is done by providing resources and support to their members in the educational, healthcare, or recovery services fields.

Next Step Recovery provides gender-specific addiction treatment programs to men in Asheville and the surrounding areas with an emphasis on relapse prevention. The rehab center provides extensive mental health support and holistic resources for those early on in their recovery journey, along with outdoor adventure therapy for long-term healing and self-discovery.

“Our membership with NATSAP will allow us to serve more men impacted by substance abuse,” Stader concludes. “At the end of the day, the more effectively we can provide healing to our community, the better.”

To learn more about Next Step Recovery and its addiction therapy programs, reach out at (855) 462-1850 or online at https://www.nextsteprecovery.com/.

To learn more about NATSAP, visit https://natsap.org/.

Next Step Recovery | Drug & Alcohol Rehab Asheville

900 Hendersonville Rd, Ste 203

Asheville, NC

(855) 462-1850

Share article on social media or email:

Northeast Delta HSA’s Integrated Care includes ‘art as medicine’ for Region 8, Partners with Black Creatives Circle of North Louisiana


Northeast Delta HSA's Integrated Care includes 'art as medicine' for Region 8, Partners with Black Creatives Circle of North Louisiana

Northeast Delta HSA’s Integrated Care includes ‘art as medicine’ for Region 8, Partners with Black Creatives Circle of North Louisiana

“We believe there is medicine in creative expression, and the arts can help a person come alive in ways traditional treatment options can’t,” Dr. Sizer said.

Northeast Delta Human Services Authority (NEDHSA) has adopted arts as one of its integrated health care, evidence-based prevention, communications, and treatment strategies to help serve persons with mental health, addictive disorders, and developmental disabilities.

To support this work, the agency has partnered with the Black Creatives Circle of North Louisiana (BCCNL), an artist think tank designed to nurture, encourage, and discuss art-related issues with North Louisiana artisans from the African Diaspora. BCCNL encompasses animators, cartoonists, designers, filmmakers, graphic designers, illustrators, painters, photographers, printmakers, poets, orators, screenwriters, sculptors, stylists, and writers.

Through BCCNL, NEDHSA will be establishing five murals in downtown development districts throughout the region to heal and restore the places where people live, work, play, and worship.

NEDHSA Executive Director Dr. Monteic A Sizer said the agency “intends to help make Northeast Louisiana a regional creative hub, a preferred destination that will generate much-needed regional economic development, diversity, job creation, and more.”

“We believe there is medicine in creative expression, and the arts can help a person come alive in ways traditional treatment options can’t,” Dr. Sizer said. “We intend to help create an environment where dreams are realized, families are strong, bodies are healthy, community institutions are thriving, and spirits are renewed.”

According to the Americans for the Arts, 69 percent of the United States population believe the arts “lift me up beyond everyday experiences,” 73 percent feel the arts give them “pure pleasure to experience and participate in,” and 81 percent say the arts are a “positive experience in a troubled world.”

In April, NEDHSA and BCCNL revealed NEDHSA’s first wall art in downtown Monroe’s Art Alley to help bring awareness and reduce mental health and addiction-related stigma.

BCCNL President Vitus Shell said murals are “direct and great ways to express a community’s concerns and needs, envisioning a new future and safer space for the people.”

“Kids and the rest of the community can see themselves in a new light,” Shell said. “Murals can enforce themes for the people and show that someone cares about their quality of life.”

Shell said BCCNL looks like the city’s majority, and “we use our voices and talent to speak up for the unheard.”

“Artists are the visionaries of our neighborhoods, so with NEDHSA, this partnership is perfect,” Shell said. “The history and mission of NEDHSA align with our goals of empowering creatives to create change in any way imaginable.”

NEDHSA has brought many art initiatives to the region, such as psychodramas, Jiggaerobics, hip hop-to-prevention efforts, and partnering with arts and communications programs at regional colleges and universities. And on May 27 and 28, the agency will be presenting two free showings of “Alky-Users: An Ongoing Tragedy” at the University of Louisiana Monroe’s Brown Theatre beginning at 7 p.m. each night.

In December 2021, NEDHSA sponsored a mural created by the University of Louisiana Monroe Honors Art Class and the Art & Entrepreneurship Class that was designed and created as a public art project to inspire ULM students to seek help, destigmatize seeking help, and provide solutions to help overcome mental health issues. Since then, the agency has displayed the mural at the Northeast Louisiana Delta African American Heritage Museum in Monroe, Union Museum of History & Art in Farmerville, Madison Parish High School in Tallulah, and the Chennault Aviation Museum in Monroe.

Dr. Sizer said art could be that spark that further “ignites better regional population health, racial unity, economic opportunities for all, and pride in where we call home.”

“It’s our time to create a place we are all proud of, a place where we foster hope and opportunities for all, Dr. Sizer said. “There is no better time than now. This is our now time.”

Share article on social media or email:

Ideal Option Releases Patient Outcomes Data to Show Effectiveness of Specialized Treatment for Fentanyl and Polysubstance Use


Ideal Option, a national leader in outpatient medication-assisted treatment for addiction to opioids, methamphetamine, alcohol and other substances, has released its 2021 Annual Patient Outcomes Report for patients living in Alaska State.

This report contains an aggregated view of patients’ geographic and demographic characteristics, their stage and duration of care, adherence to medication, and their substance use over time based on lab specimens regularly collected during 2021 from more than 720 patients.

The data support the effectiveness of treating addiction with FDA-approved medications combined with regular lab testing to verify medication adherence, create accountability, and ensure patient safety.

Among Alaska patients who remained in treatment from initiation to the maintenance stage of care during 2021, the report shows:


  • 91% less total opioid use
  • 96% less fentanyl use
  • 93% less heroin use
  • 86% less methamphetamine use
  • 67% less benzodiazepine use

The report also reveals a significant escalation in synthetic drug use in 2021 among enrolling patients, particularly fentanyl. Fentanyl positive rates at enrollment were up by 192% displacing heroin positive rates which were down by 28% compared to 2020. In addition, 53% of patients tested positive for multiple substances at enrollment, most commonly methamphetamine and opioids. Although no FDA-approved medications exist for treating isolated stimulant use disorder, Ideal Option’s data reveals that buprenorphine is highly effective for reducing methamphetamine use among polysubstance users.

“Over the 2020-21 period, positive rates for fentanyl eclipsed the use of all other types of opioids in the enrolling population.” said Tim Kilgallon, CEO at Ideal Option. “Recognizing this, Ideal Option implemented new clinical protocols and programs to better support patients transitioning from fentanyl to buprenorphine and maintained a regular cadence of lab testing to ensure patient safety and adherence to prescribed medications.”

This data corroborates state reports of the prevalent role that fentanyl and methamphetamine now play in the substance use epidemic. Street drugs of all types increasingly contain fentanyl, often masquerading as prescription tablets and capsules.

According to the Alaska Department of Health and Social Services (DHSS), drug overdose deaths increased 68% from 146 deaths in 2020 to 245 in 2021.

“This increase continues to be driven primarily by fentanyl, a very powerful opioid often found in counterfeit pills and a variety of illicit drugs, with six out of every 10 drug overdose deaths in Alaska involving fentanyl,” said Alaska’s Chief Medical Officer Dr. Anne Zink. In addition, of the 140 fentanyl overdose deaths that occurred, 61% also involved methamphetamine while 28% also involved heroin.

View the full Ideal Option 2021 Annual Patient Outcomes Report for Alaska State here: https://www.idealoption.com/patient-outcomes.

Ideal Option has helped more than 50,000 patients through a network of 76 outpatient clinics across 10 states: Alaska, Arkansas, Idaho, Maryland, Minnesota, Montana, New Mexico, North Dakota, Oregon and Washington.

With no waitlists and most forms of insurance accepted, including Medicare and Medicaid, patients can typically get started on treatment for fentanyl, heroin, methamphetamine, alcohol, or other substances within 1-3 business days.

Patients can make an appointment by calling 1.877.522.1275 or visiting http://www.idealoption.com.

About Ideal Option Headquartered in Kennewick, Washington, Ideal Option was founded in 2012 and has since helped more than 50,000 patients through a network of 76 office-based medication-assisted treatment (MAT) clinics across 10 states. With a mission to serve under-served communities, Ideal Option accepts all forms of insurance including Medicaid and Medicare. Financial assistance and payment plans are also available.

Ideal Option’s team of medical providers carry certifications in Addiction and Emergency Medicine, Internal, and Family Medicine, among other specialties. The company also employs social workers, caseworkers, counselors, and mental health practitioners. This holistic approach helps drive positive outcomes, including family stability, stable housing, improved overall health, and reduced rates of recidivism.

In all the communities it serves, Ideal Option collaborates with existing stakeholders and providers to improve the continuum of care. This approach includes partnerships with emergency rooms and county jail systems, where individuals with substance use disorder often appear, as well as collaborating with numerous support agencies and municipal programs addressing social needs such as housing, mental health, and nutrition support.

Share article on social media or email: